ARTICLE | Clinical News
RF-1051 oral human steroidal hormone: SUPG plans to begin a Phase II trial
April 22, 1996 7:00 AM UTC
SuperGen Inc. (SUPG), Emeryville, Calif. Product: RF-1051 oral human steroidal hormone Indication: Obesity Status: SUPG plans to begin a Phase II trial, using an intermittent dosing schedule of every ...